Skip to main content

eEqvero New conversation

Companies Watchlist Deep research Financial analysis My documents AI integrations

Insights Plans & usage Help Settings

Language

Loading data

Iambic Therapeutics, Inc. (IAM) · Company profile · Eqvero

IA

Iambic Therapeutics, Inc.

IAMNasdaq

10/17/2026

公司公告

8-K 2026-10-16 8-K

报告期截至 2026-10-16。

10/17/2026

公司公告

8-K 2026-10-16 EX-3.2

报告期截至 2026-10-16。

10/17/2026

公司公告

8-K 2026-10-16 EX-3.1

报告期截至 2026-10-16。

10/16/2026

424B4申报

424B4 2026-10-15 424B4

公司提交424B4申报，可查看官方原文。

10/15/2026

EFFECT申报

EFFECT 2026-10-14 EFFECT

公司提交EFFECT申报，可查看官方原文。

10/15/2026

S-8申报

S-8 2026-10-15 S-8

公司提交S-8申报，可查看官方原文。

10/08/2026

S-1/A申报

S-1/A 2026-10-08 EX-10.3

公司提交S-1/A申报，可查看官方原文。

10/08/2026

S-1/A申报

S-1/A 2026-10-08 S-1/A

公司提交S-1/A申报，可查看官方原文。

10/08/2026

S-1/A申报

S-1/A 2026-10-08 EX-10.4

公司提交S-1/A申报，可查看官方原文。

10/08/2026

S-1/A申报

S-1/A 2026-10-08 EX-3.1

公司提交S-1/A申报，可查看官方原文。

10/08/2026

S-1/A申报

S-1/A 2026-10-08 EX-10.5

公司提交S-1/A申报，可查看官方原文。

09/22/2026

S-1申报

S-1 2026-09-21 EX-10.7

公司提交S-1申报，可查看官方原文。

09/22/2026

S-1申报

S-1/A 2026-10-08 Form of Amended and Restated Certificate of Incorporation of the Registrant, to be in effect upon completion of this offering

公司提交S-1申报，可查看官方原文。

09/22/2026

S-1申报

S-1 2026-09-21 EX-4.1

公司提交S-1申报，可查看官方原文。

09/22/2026

S-1申报

S-1 2026-09-21 EX-3.1

公司提交S-1申报，可查看官方原文。

09/22/2026

S-1申报

S-1 2026-09-21 EX-10.8

公司提交S-1申报，可查看官方原文。

09/22/2026

S-1申报

S-1 2026-09-21 EX-10.11

公司提交S-1申报，可查看官方原文。

09/22/2026

S-1申报

S-1 2026-09-21 EX-10.15

公司提交S-1申报，可查看官方原文。

09/22/2026

S-1申报

S-1 2026-09-21 EX-10.16

公司提交S-1申报，可查看官方原文。

09/22/2026

S-1申报

S-1 2026-09-21 EX-3.3

公司提交S-1申报，可查看官方原文。

Research this company's operations and risks

Shareholder returns and capital allocationAnalyze Iambic Therapeutics, Inc.'s major-shareholder disposals, buybacks, related-party transactions and executive compensation over the past three years, and their effects on shareholder returns, company cash spending and future risk allocation.Earnings qualityDo Iambic Therapeutics, Inc.'s profits match its operating cash flows? Are receivables, inventories or one-off gains supporting reported earnings?Unusual capital transactionsReview Iambic Therapeutics, Inc.'s financing, acquisitions, goodwill and share-capital changes over the past three years for unusual transactions that warrant attention.Quantitative analysisValuation, portfolio risk, factor attribution and option pricing

Quotes are end-of-day data. Content is for research purposes and is not investment advice.